|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,618 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,063 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
402 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
938 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
938 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
799 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
824 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
|
03 Mar 2026 |
4,956 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
32,229 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
4,561 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
|
03 Mar 2026 |
4,956 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
32,229 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
7,650 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
4,561 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,072 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,618 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
560 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,063 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
498 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
484 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
938 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
478 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
938 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
2,813 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
6,876 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
|
03 Mar 2026 |
4,648 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,225 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,035 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
3,125 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
2,500 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
6,250 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
7,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
9,375 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
64,375 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
58,333 |
41,667
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Scott Braunstein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
25,000 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Scott Braunstein
|
Director |
|
03 Mar 2026 |
4,956 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
218,250 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
371,875 |
265,625
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
31,250 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
34,375 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
|
03 Mar 2026 |
64,102 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
10,417 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
7,500 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
18,750 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
37,500 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
8,334 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
25,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,063 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,618 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
4,561 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
|
03 Mar 2026 |
4,956 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Lori Lyons-Williams
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
32,229 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
2,813 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
938 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
32,229 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
4,561 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,618 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,063 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
938 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
417 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
1,917 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
521 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
521 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
2,083 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
|
03 Mar 2026 |
4,956 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Ashley Dombkowski
|
Director |
|
03 Mar 2026 |
4,956 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Ashley Dombkowski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Mar 2026 |
25,000 |
0
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2026 |
4,956 |
4,956
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2026 |
4,956 |
4,956
(0%)
|
0%
|
|
0
|
Common Stock |
|
Scott Braunstein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2026 |
4,956 |
4,956
(0%)
|
0%
|
|
0
|
Common Stock |
|
Lori Lyons-Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2026 |
4,956 |
4,956
(0%)
|
0%
|
|
0
|
Common Stock |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2026 |
4,956 |
4,956
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashley Dombkowski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2026 |
4,956 |
4,956
(0%)
|
0%
|
|
0
|
Common Stock |
|
Scott Braunstein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2025 |
25,000 |
25,000
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Ashley Dombkowski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2025 |
25,000 |
25,000
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2025 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2025 |
100,000 |
100,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2025 |
637,500 |
637,500
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2025 |
257,832 |
257,832
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2025 |
257,832 |
257,832
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2025 |
257,832 |
257,832
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2025 |
257,832 |
257,832
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
61,202 |
61,202
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
49,432 |
49,432
|
-
|
|
-
|
Director Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2025 |
450,000 |
450,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2025 |
515,000 |
515,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2025 |
1,746,000 |
1,746,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
75,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
56,000 |
56,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
7,807 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
7,807 |
7,807
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
20,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
20,000 |
20,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
55,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
55,000 |
55,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
55,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
55,000 |
55,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
56,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
20,000 |
20,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
75,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
56,000 |
56,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
56,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
55,000 |
55,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
55,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
50,000 |
50,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
20,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
275,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
83,333 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
83,333 |
83,333
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
60,000 |
60,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
150,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
150,000 |
150,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
300,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
300,000 |
300,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Nov 2024 |
250,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
250,000 |
250,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Nov 2024 |
275,000 |
275,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2024 |
36,490 |
36,490
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2024 |
36,490 |
36,490
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2024 |
36,490 |
36,490
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2024 |
36,490 |
36,490
|
-
|
|
-
|
Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2024 |
36,490 |
36,490
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
22 May 2024 |
36,490 |
36,490
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Mar 2024 |
8,574 |
8,574
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Mar 2024 |
11,871 |
11,871
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
28 Mar 2024 |
6,925 |
6,925
|
-
|
|
-
|
Stock Option (right to buy) |
|
G. Brockstedt Dirk
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2024 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Wong Brian Russell
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2024 |
275,000 |
275,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2024 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brockstedt Dirk G.
|
CHIEF SCIENTIFIC OFFICER |
Sale of securities on an exchange or to another person at price $ 22.78 per share. |
05 Jan 2024 |
898 |
27,820
(0%)
|
0%
|
22.8 |
20,456
|
Common Stock |
|
Brockstedt Dirk G.
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Dec 2023 |
8,000 |
7,690
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
G. Brockstedt Dirk
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
29 Dec 2023 |
8,000 |
27,070
(0%)
|
0%
|
6.2 |
49,440
|
Common Stock |
|
Ho William
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 21.68 per share. |
21 Dec 2023 |
2,500 |
15,020
(0%)
|
0%
|
21.7 |
54,200
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.92 per share. |
18 Aug 2023 |
2,500 |
21,289
(0%)
|
0%
|
18.9 |
47,300
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Jul 2023 |
460 |
1,841
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. |
28 Jul 2023 |
460 |
23,789
(0%)
|
0%
|
12 |
5,520
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. |
23 Jun 2023 |
920 |
23,329
(0%)
|
0%
|
12 |
11,040
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 Jun 2023 |
920 |
2,301
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,940 |
12,940
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,940 |
12,940
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,940 |
12,940
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,940 |
12,940
|
-
|
|
-
|
Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,940 |
12,940
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
24 May 2023 |
12,940 |
12,940
|
-
|
|
-
|
Stock Option (right to buy) |
|
William Ho
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.88 per share. |
19 Apr 2023 |
5,000 |
20,992
(0%)
|
0%
|
18.9 |
94,400
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Apr 2023 |
460 |
3,802
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. |
13 Apr 2023 |
460 |
22,381
(0%)
|
0%
|
12 |
5,520
|
Common Stock |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2023 |
4,477 |
4,477
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2023 |
6,026 |
6,026
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
31 Mar 2023 |
3,616 |
3,616
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
14 Mar 2023 |
2,500 |
6,500
(0%)
|
0%
|
20.1 |
50,125
|
Common Stock |
|
Wendye Robbins
|
Director |
|
14 Mar 2023 |
600 |
14,900
(0%)
|
0%
|
20.0 |
11,970
|
Common Stock |
|
Wendye Robbins
|
Director |
|
14 Mar 2023 |
400 |
14,300
(0%)
|
0%
|
18.5 |
7,392
|
Common Stock |
|
Wendye Robbins
|
Director |
|
14 Mar 2023 |
1,500 |
13,900
(0%)
|
0%
|
18.8 |
28,125
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 29.62 per share. |
07 Mar 2023 |
5,000 |
25,532
(0%)
|
0%
|
29.6 |
148,100
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. |
03 Mar 2023 |
460 |
30,532
(0%)
|
0%
|
12 |
5,520
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Mar 2023 |
460 |
3,681
|
-
|
|
-
|
Option (right to buy) |
|
William Ho
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2023 |
56,000 |
56,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2023 |
56,000 |
56,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2023 |
250,000 |
250,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
William Ho
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 30.00 per share. |
24 Jan 2023 |
5,000 |
30,072
(0%)
|
0%
|
30 |
150,000
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 25.56 per share. |
19 Jan 2023 |
5,000 |
35,072
(0%)
|
0%
|
25.6 |
127,800
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. |
12 Jan 2023 |
1,042 |
38,692
(0%)
|
0%
|
6.3 |
6,565
|
Common Stock |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Jan 2023 |
1,380 |
4,601
|
-
|
|
-
|
Option (right to buy) |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Jan 2023 |
1,042 |
0
|
-
|
|
-
|
Option (right to buy) |
|
William Ho
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. |
12 Jan 2023 |
1,380 |
40,072
(0%)
|
0%
|
12 |
16,560
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 21.97 per share. |
05 Jan 2023 |
742 |
19,070
(0%)
|
0%
|
22.0 |
16,299
|
Common Stock |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lori Lyons-Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
25 May 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
10 May 2022 |
2,500 |
13,800
(0%)
|
0%
|
11.8 |
29,500
|
Common Stock |
|
Wendye Robbins
|
Director |
|
10 May 2022 |
2,000 |
11,300
(0%)
|
0%
|
10.5 |
21,080
|
Common Stock |
|
Wendye Robbins
|
Director |
|
10 May 2022 |
400 |
4,000
(0%)
|
0%
|
10.6 |
4,248
|
Common Stock |
|
Wendye Robbins
|
Director |
|
10 May 2022 |
600 |
3,600
(0%)
|
0%
|
10.5 |
6,294
|
Common Stock |
|
Wendye Robbins
|
Director |
|
10 May 2022 |
1,000 |
3,000
(0%)
|
0%
|
10.5 |
10,510
|
Common Stock |
|
Wendye Robbins
|
Director |
|
10 May 2022 |
500 |
1,800
(0%)
|
0%
|
11.3 |
5,650
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.05 per share. |
04 May 2022 |
720 |
19,812
(0%)
|
0%
|
15.1 |
10,836
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 23.05 per share. |
11 Apr 2022 |
2,647 |
19,812
(0%)
|
0%
|
23.0 |
61,013
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 Apr 2022 |
2,647 |
22,459
(0%)
|
0%
|
6.2 |
16,358
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Apr 2022 |
1,290 |
2,113
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Apr 2022 |
1,357 |
15,690
|
-
|
|
-
|
Option (right to buy) |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
3,213 |
3,213
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
3,868 |
3,868
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
5,207 |
5,207
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
31 Mar 2022 |
3,124 |
3,124
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 23.91 per share. |
11 Mar 2022 |
2,648 |
19,812
(0%)
|
0%
|
23.9 |
63,314
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 Mar 2022 |
2,648 |
22,460
(0%)
|
0%
|
6.2 |
16,365
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Mar 2022 |
2,648 |
17,047
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Feb 2022 |
2,647 |
19,695
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 Feb 2022 |
2,647 |
22,459
(0%)
|
0%
|
6.2 |
16,358
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 22.47 per share. |
11 Feb 2022 |
2,647 |
19,812
(0%)
|
0%
|
22.5 |
59,478
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jan 2022 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jan 2022 |
300,000 |
300,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 Jan 2022 |
2,648 |
22,460
(0%)
|
0%
|
6.2 |
16,365
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 32.16 per share. |
11 Jan 2022 |
2,648 |
19,812
(0%)
|
0%
|
32.2 |
85,160
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Jan 2022 |
2,648 |
22,342
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. |
03 Jan 2022 |
820 |
18,992
(0%)
|
0%
|
36.7 |
30,119
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 30.88 per share. |
10 Dec 2021 |
2,647 |
19,812
(0%)
|
0%
|
30.9 |
81,739
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Dec 2021 |
2,647 |
611
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. |
10 Dec 2021 |
2,647 |
22,459
(0%)
|
0%
|
6.3 |
16,676
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. |
11 Nov 2021 |
2,648 |
22,460
(0%)
|
0%
|
6.3 |
16,682
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Nov 2021 |
2,648 |
3,258
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 35.69 per share. |
11 Nov 2021 |
2,648 |
19,812
(0%)
|
0%
|
35.7 |
94,507
|
Common Stock |
|
Lori Lyons-Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Nov 2021 |
22,500 |
22,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
18 Oct 2021 |
500 |
9,300
(0%)
|
0%
|
30.7 |
15,350
|
Common Stock |
|
Wendye Robbins
|
Director |
|
13 Oct 2021 |
400 |
8,800
(0%)
|
0%
|
29.7 |
11,876
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 30.78 per share. |
11 Oct 2021 |
2,647 |
19,812
(0%)
|
0%
|
30.8 |
81,475
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Oct 2021 |
2,647 |
24,990
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 Oct 2021 |
2,647 |
22,459
(0%)
|
0%
|
6.2 |
16,358
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 35.78 per share. |
10 Sep 2021 |
2,648 |
19,812
(0%)
|
0%
|
35.8 |
94,745
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Sep 2021 |
2,648 |
27,637
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
10 Sep 2021 |
2,648 |
22,460
(0%)
|
0%
|
6.2 |
16,365
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Aug 2021 |
500 |
500
(0%)
|
0%
|
31.1 |
15,557
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Aug 2021 |
25 |
2,000
(0%)
|
0%
|
30.8 |
770
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Aug 2021 |
500 |
1,975
(0%)
|
0%
|
31 |
15,500
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Aug 2021 |
225 |
1,475
(0%)
|
0%
|
31 |
6,975
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Aug 2021 |
250 |
1,250
(0%)
|
0%
|
32.1 |
8,013
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Aug 2021 |
500 |
1,000
(0%)
|
0%
|
31.5 |
15,750
|
Common Stock |
|
Wendye Robbins
|
Director |
|
20 Aug 2021 |
100 |
7,900
(0%)
|
0%
|
29.8 |
2,982
|
Common Stock |
|
Wendye Robbins
|
Director |
|
20 Aug 2021 |
500 |
8,400
(0%)
|
0%
|
29.5 |
14,735
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 Aug 2021 |
2,647 |
22,459
(0%)
|
0%
|
6.2 |
16,358
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 31.19 per share. |
11 Aug 2021 |
2,647 |
19,812
(0%)
|
0%
|
31.2 |
82,560
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Aug 2021 |
2,647 |
30,285
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
12 Jul 2021 |
2,648 |
22,460
(0%)
|
0%
|
6.2 |
16,365
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Jul 2021 |
2,648 |
32,932
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 33.53 per share. |
12 Jul 2021 |
2,648 |
19,812
(0%)
|
0%
|
33.5 |
88,787
|
Common Stock |
|
Wendye Robbins
|
Director |
|
07 Jul 2021 |
600 |
7,400
(0%)
|
0%
|
30.2 |
18,120
|
Common Stock |
|
Wendye Robbins
|
Director |
|
07 Jul 2021 |
400 |
7,800
(0%)
|
0%
|
30.2 |
12,060
|
Common Stock |
|
Wendye Robbins
|
Director |
|
16 Jun 2021 |
500 |
6,600
(0%)
|
0%
|
31.5 |
15,770
|
Common Stock |
|
Wendye Robbins
|
Director |
|
16 Jun 2021 |
5 |
305
(0%)
|
0%
|
31.6 |
158
|
Common Stock |
|
Wendye Robbins
|
Director |
|
16 Jun 2021 |
100 |
6,800
(0%)
|
0%
|
31.5 |
3,153
|
Common Stock |
|
Wendye Robbins
|
Director |
|
16 Jun 2021 |
100 |
6,700
(0%)
|
0%
|
31.6 |
3,156
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Jun 2021 |
2,647 |
35,580
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 Jun 2021 |
2,647 |
22,459
(0%)
|
0%
|
6.2 |
16,358
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.55 per share. |
11 Jun 2021 |
2,647 |
19,812
(0%)
|
0%
|
18.6 |
49,102
|
Common Stock |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Peter Svennilson
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
28 May 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
11 May 2021 |
2,648 |
22,460
(0%)
|
0%
|
6.2 |
16,365
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 May 2021 |
2,648 |
38,227
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.19 per share. |
11 May 2021 |
2,648 |
19,812
(0%)
|
0%
|
18.2 |
48,167
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 21.56 per share. |
05 May 2021 |
2,084 |
19,812
(0%)
|
0%
|
21.6 |
44,931
|
Common Stock |
|
Wendye Robbins
|
Director |
|
13 Apr 2021 |
300 |
6,100
(0%)
|
0%
|
19.4 |
5,820
|
Common Stock |
|
Wendye Robbins
|
Director |
|
13 Apr 2021 |
400 |
5,800
(0%)
|
0%
|
19.5 |
7,800
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
74 |
5,100
(0%)
|
0%
|
21.1 |
1,559
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
500 |
1,300
(0%)
|
0%
|
21.1 |
10,545
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
300 |
800
(0%)
|
0%
|
21.0 |
6,286
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
300 |
5,400
(0%)
|
0%
|
21.2 |
6,372
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
100 |
5,026
(0%)
|
0%
|
21 |
2,100
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
21 |
4,926
(0%)
|
0%
|
21 |
441
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
79 |
4,905
(0%)
|
0%
|
21.0 |
1,658
|
Common Stock |
|
Wendye Robbins
|
Director |
|
09 Apr 2021 |
26 |
4,826
(0%)
|
0%
|
20.9 |
544
|
Common Stock |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2021 |
3,822 |
3,822
|
-
|
|
-
|
Stock Option (right to buy) |
|
Peter Svennilson
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2021 |
2,229 |
2,229
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
31 Mar 2021 |
3,025 |
3,025
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 21.22 per share. |
16 Feb 2021 |
9,877 |
19,812
(0%)
|
0%
|
21.2 |
209,590
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. |
16 Feb 2021 |
8,245 |
28,057
(0%)
|
0%
|
6.3 |
51,944
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
16 Feb 2021 |
1,632 |
29,689
(0%)
|
0%
|
6.2 |
10,086
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Feb 2021 |
8,245 |
5,906
|
-
|
|
-
|
Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Feb 2021 |
1,632 |
3,403
|
-
|
|
-
|
Option (right to buy) |
|
Wendye Robbins
|
Director |
|
11 Feb 2021 |
300 |
300
(0%)
|
0%
|
|
0
|
Common Stock |
|
Wendye Robbins
|
Director |
|
11 Feb 2021 |
300 |
4,800
(0%)
|
0%
|
|
0
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jan 2021 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jan 2021 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Karen C. Lam
|
VP, Finance and Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jan 2021 |
18,000 |
18,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 19.76 per share. |
05 Jan 2021 |
821 |
18,735
(0%)
|
0%
|
19.8 |
16,225
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 19.68 per share. |
05 Jan 2021 |
1,179 |
17,556
(0%)
|
0%
|
19.7 |
23,203
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Dec 2020 |
9,300 |
45,910
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
30 Dec 2020 |
9,300 |
19,556
(0%)
|
0%
|
6.2 |
57,474
|
Common Stock |
|
William J. Rieflin
|
Director |
Purchase of securities on an exchange or from another person at price $ 16.22 per share. |
19 Nov 2020 |
10,000 |
18,000
(0%)
|
0%
|
16.2 |
162,200
|
Common Stock |
|
Wendye Robbins
|
Director |
|
19 Nov 2020 |
500 |
500
(0%)
|
0%
|
16.1 |
8,045
|
Common Stock |
|
Wendye Robbins
|
Director |
|
19 Nov 2020 |
500 |
5,100
(0%)
|
0%
|
16.1 |
8,040
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. |
16 Nov 2020 |
6,508 |
20,133
(0%)
|
0%
|
6.3 |
41,000
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Nov 2020 |
6,508 |
14,151
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Nov 2020 |
3,369 |
5,035
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 17.01 per share. |
16 Nov 2020 |
9,877 |
10,256
(0%)
|
0%
|
17.0 |
168,008
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
16 Nov 2020 |
3,369 |
13,625
(0%)
|
0%
|
6.2 |
20,820
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 28.06 per share. |
02 Nov 2020 |
1,910 |
10,256
(0%)
|
0%
|
28.1 |
53,595
|
Common Stock |
|
Karen C. Lam
|
VP, Finance and Controller |
Sale of securities on an exchange or to another person at price $ 28.14 per share. |
02 Nov 2020 |
2,022 |
12,735
(0%)
|
0%
|
28.1 |
56,899
|
Common Stock |
|
Brian Russell Wong
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 40.05 per share. |
12 Oct 2020 |
20,000 |
337,000
(1%)
|
0%
|
40.1 |
801,040
|
Common Stock |
|
Wendye Robbins
|
Director |
|
28 Sep 2020 |
200 |
6,550
(0%)
|
0%
|
28.6 |
5,710
|
Common Stock |
|
Wendye Robbins
|
Director |
|
28 Sep 2020 |
300 |
6,350
(0%)
|
0%
|
28.8 |
8,640
|
Common Stock |
|
Brian Russell Wong
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 30.06 per share. |
23 Sep 2020 |
2,000 |
357,000
(1%)
|
0%
|
30.1 |
60,120
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Sep 2020 |
100 |
5,850
(0%)
|
0%
|
29.5 |
2,950
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Sep 2020 |
300 |
5,750
(0%)
|
0%
|
29.1 |
8,730
|
Common Stock |
|
Wendye Robbins
|
Director |
|
23 Sep 2020 |
200 |
6,050
(0%)
|
0%
|
28 |
5,600
|
Common Stock |
|
Peter Svennilson
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 30.85 per share. |
22 Sep 2020 |
608,000 |
3,835,679
(15%)
|
2%
|
30.9 |
18,756,800
|
Common Stock |
|
Peter Svennilson
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 22.75 per share. |
17 Aug 2020 |
538,654 |
4,443,679
(18%)
|
2%
|
22.8 |
12,254,379
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 23.13 per share. |
17 Aug 2020 |
1,502 |
18,631
(0%)
|
0%
|
23.1 |
34,741
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 24.07 per share. |
17 Aug 2020 |
8,375 |
10,256
(0%)
|
0%
|
24.1 |
201,586
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Aug 2020 |
9,877 |
58,579
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
17 Aug 2020 |
9,877 |
20,133
(0%)
|
0%
|
6.2 |
61,040
|
Common Stock |
|
Wendye Robbins
|
Director |
|
24 Jul 2020 |
400 |
5,450
(0%)
|
0%
|
22.8 |
9,100
|
Common Stock |
|
Wendye Robbins
|
Director |
|
24 Jul 2020 |
500 |
5,050
(0%)
|
0%
|
22.3 |
11,125
|
Common Stock |
|
Wendye Robbins
|
Director |
|
29 Jun 2020 |
500 |
4,100
(0%)
|
0%
|
26.3 |
13,150
|
Common Stock |
|
Wendye Robbins
|
Director |
|
29 Jun 2020 |
500 |
4,600
(0%)
|
0%
|
26.5 |
13,250
|
Common Stock |
|
Wendye Robbins
|
Director |
|
29 Jun 2020 |
1,650 |
3,600
(0%)
|
0%
|
26.0 |
42,933
|
Common Stock |
|
Michael F. Giordano
|
Director |
Sale of securities on an exchange or to another person at price $ 33.37 per share. |
25 Jun 2020 |
19,013 |
0
(0%)
|
0%
|
33.4 |
634,464
|
Common Stock |
|
Michael F. Giordano
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. |
25 Jun 2020 |
8,944 |
8,944
(0%)
|
0%
|
12 |
107,328
|
Common Stock |
|
Michael F. Giordano
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
25 Jun 2020 |
10,069 |
10,069
(0%)
|
0%
|
6.2 |
62,226
|
Common Stock |
|
Michael F. Giordano
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Jun 2020 |
8,944 |
6,390
|
-
|
|
-
|
Stock Option (right to buy) |
|
Michael F. Giordano
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Jun 2020 |
10,069 |
6,597
|
-
|
|
-
|
Stock Option (right to buy) |
|
Karen C. Lam
|
VP, Finance & Controller |
Sale of securities on an exchange or to another person at price $ 35.00 per share. |
25 Jun 2020 |
875 |
12,735
(0%)
|
0%
|
35 |
30,625
|
Common Stock |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Peter Svennilson
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
22,500 |
22,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
18 Jun 2020 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.00 per share. |
15 May 2020 |
9,877 |
10,256
(0%)
|
0%
|
15 |
148,155
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 May 2020 |
9,877 |
68,456
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.18 per share. |
15 May 2020 |
9,877 |
20,133
(0%)
|
0%
|
6.2 |
61,040
|
Common Stock |
|
Karen C. Lam
|
VP, Finance & Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. |
12 May 2020 |
2,777 |
13,610
(0%)
|
0%
|
1.9 |
5,165
|
Common Stock |
|
Karen C. Lam
|
VP, Finance & Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 May 2020 |
2,777 |
5,556
|
-
|
|
-
|
Stock option (right to buy) |
|
Karen C. Lam
|
VP, Finance & Controller |
Sale of securities on an exchange or to another person at price $ 15.40 per share. |
07 May 2020 |
1,831 |
10,833
(0%)
|
0%
|
15.4 |
28,197
|
Common Stock |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2020 |
3,984 |
3,984
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
31 Mar 2020 |
3,154 |
3,154
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2020 |
8,000 |
8,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Dirk G. Brockstedt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2020 |
22,000 |
147,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian Russell Wong
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2020 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Karen C. Lam
|
VP, Finance & Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2020 |
2,500 |
10,833
(0%)
|
0%
|
|
0
|
Common Stock |
|
Karen C. Lam
|
VP, Finance & Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2020 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
31 Dec 2019 |
22 |
1,950
(0%)
|
0%
|
23.1 |
508
|
Common Stock |
|
Wendye Robbins
|
Director |
|
31 Dec 2019 |
200 |
1,928
(0%)
|
0%
|
21.9 |
4,374
|
Common Stock |
|
Wendye Robbins
|
Director |
|
31 Dec 2019 |
78 |
1,728
(0%)
|
0%
|
26.6 |
2,075
|
Common Stock |
|
Wendye Robbins
|
Director |
|
31 Dec 2019 |
50 |
1,650
(0%)
|
0%
|
12.8 |
638
|
Common Stock |
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2019 |
22,500 |
22,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
David V. Goeddel
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 12.00 per share. |
04 Nov 2019 |
625,000 |
4,982,333
(20%)
|
2%
|
12 |
7,500,000
|
Common Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
1,454,016 |
1,454,016
(5%)
|
6%
|
|
-
|
Common Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
145,401 |
1,599,417
(6%)
|
0%
|
|
-
|
Common Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
145,401 |
145,401
(0%)
|
0%
|
|
-
|
Common Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
14,781,963 |
0
|
-
|
|
-
|
Series A Preferred Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
7,000,000 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
4,362,050 |
0
|
-
|
|
-
|
Series C Preferred Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
872,410 |
0
|
-
|
|
-
|
Series C-2 Preferred Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
872,410 |
0
|
-
|
|
-
|
Series C-2 Preferred Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
8,724,100 |
0
|
-
|
|
-
|
Series C Preferred Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
2,463,659 |
2,463,659
(10%)
|
11%
|
|
-
|
Common Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
1,166,666 |
3,630,325
(14%)
|
5%
|
|
-
|
Common Stock |
|
David V. Goeddel
|
Director, Ten Percent Owner |
|
04 Nov 2019 |
727,008 |
4,357,333
(17%)
|
3%
|
|
-
|
Common Stock |
|
William J. Rieflin
|
Director |
|
04 Nov 2019 |
16,666 |
76,722
(0%)
|
0%
|
|
-
|
Common Stock |
|
William J. Rieflin
|
Director |
|
04 Nov 2019 |
43,390 |
60,056
(0%)
|
0%
|
|
-
|
Common Stock |
|
William J. Rieflin
|
Director |
|
04 Nov 2019 |
100,000 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
William J. Rieflin
|
Director |
|
04 Nov 2019 |
260,344 |
0
|
-
|
|
-
|
Series A Preferred Stock |
|
William J. Rieflin
|
Director |
Purchase of securities on an exchange or from another person at price $ 12.00 per share. |
04 Nov 2019 |
8,000 |
8,000
(0%)
|
0%
|
12 |
96,000
|
Common Stock |
|
Brian Russell Wong
|
Director, President and CEO |
|
04 Nov 2019 |
150,000 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
Brian Russell Wong
|
Director, President and CEO |
|
04 Nov 2019 |
25,000 |
355,000
(1%)
|
0%
|
|
-
|
Common Stock |
|
Brian Russell Wong
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 12.00 per share. |
04 Nov 2019 |
25,000 |
125,000
(0%)
|
0%
|
12 |
300,000
|
Common Stock |
|
Wendye Robbins
|
Director |
|
04 Nov 2019 |
1,600 |
1,600
(0%)
|
0%
|
12 |
19,200
|
Common Stock |
|
Michael F. Giordano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2019 |
15,334 |
15,334
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2019 |
3,333 |
3,333
|
-
|
|
-
|
Stock Option (right to buy) |
|
William J. Rieflin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2019 |
15,334 |
15,334
|
-
|
|
-
|
Stock Option (right to buy) |
|
Brian Russell Wong
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2019 |
83,333 |
83,333
|
-
|
|
-
|
Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2019 |
3,333 |
3,333
|
-
|
|
-
|
Stock Option (right to buy) |
|
Linda Kozick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Oct 2019 |
15,334 |
15,334
|
-
|
|
-
|
Stock Option (right to buy) |
|
Wendye Robbins
|
Director |
|
30 Oct 2019 |
32,000 |
32,000
|
-
|
|
-
|
Stock Option (right to buy) |